04.06.10
Paris, France-based Hitex, a subsidiary of Lavipharm Group, and P.L. Thomas, Morristown, NJ, have received a letter of no objection from FDA regarding new dietary ingredient (NDI) status for Lipowheat oil natural ceramides. Patented and scientifically supported by three clinical studies, Lipowheat oral delivery of ceramides restores the skin barrier function, ensuring a healthy hydration mechanism, according to the companies. P.L. Thomas is the exclusive marketer for Lipowheat in North America.